Literature DB >> 31331739

Therapeutic and Diagnostic Implications of T Cell Scarring in Celiac Disease and Beyond.

Asbjørn Christophersen1, Louise F Risnes1, Shiva Dahal-Koirala1, Ludvig M Sollid2.   

Abstract

Few therapeutic and diagnostic tools specifically aim at T cells in autoimmune disorders, but are T cells a narrow target in these diseases? Lessons may be learned from celiac disease (CeD), one of the few autoimmune disorders where the T cell driving antigens are known, i.e. dietary gluten proteins. T cell clonotypes specific to gluten are expanded, persist for decades and express a distinct phenotype in CeD patients. Cells with this phenotype are increased also in other autoimmune conditions. Accordingly, disease-specific CD4+ T cells form an immunological scar in CeD and probably other autoimmune disorders. We discuss approaches how such T cells may be targeted for better treatment and diagnosis via their antigen specificity or via their expression of characteristic phenotypic markers.
Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Autoimmunity; HLA; T cells; celiac disease; diagnosis; therapy

Mesh:

Substances:

Year:  2019        PMID: 31331739     DOI: 10.1016/j.molmed.2019.05.009

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  8 in total

Review 1.  Current and emerging therapies for coeliac disease.

Authors:  Laura Kivelä; Alberto Caminero; Daniel A Leffler; Maria Ines Pinto-Sanchez; Jason A Tye-Din; Katri Lindfors
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-11-20       Impact factor: 46.802

2.  Dihydroorotate Dehydrogenase Inhibitors for Treating Acute Myelogenous Leukemia (AML).

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2021-01-11       Impact factor: 4.345

3.  Whole blood interleukin-2 release test to detect and characterize rare circulating gluten-specific T cell responses in coeliac disease.

Authors:  R P Anderson; G Goel; M Y Hardy; A K Russell; S Wang; E Szymczak; R Zhang; K E Goldstein; K Neff; K E Truitt; L J Williams; J L Dzuris; J A Tye-Din
Journal:  Clin Exp Immunol       Date:  2021-02-28       Impact factor: 5.732

4.  In Well-Treated Celiac Patients Low-Level Mucosal Inflammation Predicts Response to 14-day Gluten Challenge.

Authors:  Jorunn Stamnaes; Daniel Stray; Maria Stensland; Vikas K Sarna; Tuula A Nyman; Knut E A Lundin; Ludvig M Sollid
Journal:  Adv Sci (Weinh)       Date:  2021-01-04       Impact factor: 16.806

5.  Differential expression profile of gluten-specific T cells identified by single-cell RNA-seq.

Authors:  Ying Yao; Łukasz Wyrozżemski; Knut E A Lundin; Geir Kjetil Sandve; Shuo-Wang Qiao
Journal:  PLoS One       Date:  2021-10-07       Impact factor: 3.240

6.  Pathogenic T Cells in Celiac Disease Change Phenotype on Gluten Challenge: Implications for T-Cell-Directed Therapies.

Authors:  Asbjørn Christophersen; Stephanie Zühlke; Eivind G Lund; Omri Snir; Shiva Dahal-Koirala; Louise Fremgaard Risnes; Jørgen Jahnsen; Knut E A Lundin; Ludvig M Sollid
Journal:  Adv Sci (Weinh)       Date:  2021-09-08       Impact factor: 16.806

Review 7.  Immunopathogenesis and environmental triggers in coeliac disease.

Authors:  Anais Levescot; Georgia Malamut; Nadine Cerf-Bensussan
Journal:  Gut       Date:  2022-07-25       Impact factor: 31.793

Review 8.  Challenges of Monitoring the Gluten-Free Diet Adherence in the Management and Follow-Up of Patients with Celiac Disease.

Authors:  Herbert Wieser; Ángela Ruiz-Carnicer; Verónica Segura; Isabel Comino; Carolina Sousa
Journal:  Nutrients       Date:  2021-06-30       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.